Thiomersal in vaccines: a regulatory perspective WHO Consultation, Geneva, 15-16 April 2002.
Knezevic
I
I
Department of Vaccines and Biologicals, World Health Organization, Geneva, Switzerland. knezevic@who.int
Griffiths
E
E
Reigel
F
F
Dobbelaer
R
R
D004669:Encephalitis Viruses, Tick-Borne / Q000276:immunology; D005060:Europe; D007880:Legislation, Drug; D011310:Preservatives, Pharmaceutical / Q000009:adverse effects*; D013849:Thimerosal / Q000009:adverse effects*; D014481:United States; D014612:Vaccines / Q000009:adverse effects*
D011310:Preservatives, Pharmaceutical; D014612:Vaccines; D013849:Thimerosal